Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...